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RESEARCH ARTICLE
Patterns of bronchial challenge testing in Canada
Rémi Thériault BA1, Amir Raz PhD1,2,3,4
R Thériault, A Raz. Patterns of bronchial challenge testing in Canada. Can J Respir Ther 2018;54(2):41–47. doi: 10.29390/cjrt-2018-006.
Background: Bronchial challenge testing (BCT) measures airway hyperresponsiveness; asthma guidelines recommend using BCT when symptoms mani-
fest despite normal spirometry. Improper application of these guidelines commonly results in the misdiagnosis of asthma. Yet, statistics concerning BCT 
remain largely obscure. The current paper addresses this gap and explores how various health variables may elucidate adherence to asthma guidelines and 
patterns of BCT across Canadian provinces.
Methods: Using the Access to Information Act, medical financial claims for BCT (or equivalent procedures) were requested from each of the Canadian 
provinces and territories. Based on the available information (from provinces only), correlations between frequency of BCT claims and medical demo-
graphics (e.g., prevalence of respirologists, health expenditures) are reported.
Results: Controlling for population or for people with asthma, physicians from Québec claim four times more BCT per year than those in other provinces; 
physicians from Alberta close to eight-fold fewer. The number of respirologists per capita and BCT per capita correlated moderately, r(132) = 0.582, 
p < 0.001, [95% CI 0.421, 0.716]. Excluding “outliers” (i.e., British Columbia, Alberta, and Saskatchewan) greatly strengthened this correlation, r(87) = 
0.930, p < 0.001, [95% CI 0.883, 0.958].
Discussion: These findings demonstrate that provinces vary in their use of BCT. This result seems to stem, at least in part, from differences in the preva-
lence of respirologists. Interestingly, geographic region appears to wield a strong influence; in the correlation between number of tests and number of 
respirologists, physicians from Western provinces (i.e., Alberta, Saskatchewan, and British Columbia) administered fewer tests than their Eastern col-
leagues. Given the association between inadequate application of BCT and misdiagnosis of asthma, physicians should pay special attention to the 
Canadian guidelines when considering an asthma diagnosis.
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INTRODUCTION
Existing asthma guidelines [1–6] recommend that physicians confirm 
the diagnosis of asthma with objective pulmonary function testing (PFT) 
measures [7], including, but not limited to, spirometry [8] and nonspe-
cific bronchial challenge testing (BCT) [9]. This practice helps to reduce 
misdiagnosis and its societal and personal costs [10]. Without PFT, phy-
sicians risk over-diagnosing or under-diagnosing asthma by approxi-
mately 30% [11–16] and 20% [15–18], respectively. Consequently, an 
editorial in the Canadian Medical Association Journal [19] stated that 
“Failure to make the diagnosis of asthma objectively is unacceptable… 
Physicians who do not use spirometry for their asthma patients should 
not be managing asthma,” (p. 1099), although some disagree [20]. And 
yet, the little available documentation concerning frequency of PFT sug-
gests that Canada scantily meets its asthma guidelines [2]. One study [21] 
reported only 54% of individuals diagnosed with asthma ever had PFT; 
only 49% of general practitioners and 46% of physicians reported using 
PFT. In a study looking at over-diagnosis [12, 22], only 49% of patients 
went through spirometry on the initial diagnosis of asthma. Two other 
studies revealed that only 43% and 52% of diagnosed individuals 
received PFT in Ontario [23] and Nova Scotia [13], respectively. Overall, 
these findings propose that Canadian physicians resort to PFT in a sub-
optimal fashion [24].
In the presence of symptoms but normal spirometry, Canadian 
guidelines [2] recommend measuring airway hyper-responsiveness 
via BCT [9]. A rough estimate of the percentage of people requiring 
BCT can be formed from the number of patients that show normal 
spirometry despite reporting respiratory symptoms (although alterna-
tive methods besides BCT can also be used to investigate asthma 
given normal spirometry, such as bronchodilator response [25], peak 
flow monitoring and trial of therapy [26], and sputum induction and 
fractional exhaled nitric oxide [27]). The NHANES III study [28], 
based on a US sample of more than 16,000 individuals, estimated 
that more than 85% of adults older than 24 years of age with respira-
tory symptoms (including diagnosis of asthma) will have normal lung 
function as measured by spirometry. Moreover, when specifically inves-
tigated for asthma, between 55% [29] and 67% [30] of children and 
approximately 34% [31] of adults older than 50 years will typically 
show normal spirometry. In one study [32] of adults with symptoms 
of obstructive pulmonary disease, 63% had normal spirometry 
(80% excluding chronic obstructive pulmonary disease); BCT later 
identified asthma in 47% of individuals with normal spirometry. 
Despite these abovementioned data concerning normal spirometry, 
to the best of our knowledge, the only source documenting BCT is a 
survey that relied on a small convenience sample [33]. This survey esti-
mated the application of BCT in the province of Québec to approxi-
mate 5150 tests per year. Otherwise, no systematic data are readily 
obtainable on the use of BCT within Canada. This paper presents pat-
terns of BCT across Canada, speculates on potential factors influenc-
ing its use, and contextualizes these trends in relation to the Canadian 
asthma guidelines. This work will contribute to bring a unique perspec-
tive to better understand, and eventually address, the misdiagnosis of 
asthma in Canada.
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METHOD
Using the Access to Information Act, medical financial claims for BCT 
(or equivalent procedures; see Supplementary File 11 for an overview 
of how each province labels BCT) were requested from each of the 
Canadian provinces and territories (see Supplementary File 21 for exclu-
sions and details on data format and handling). Time-series data were 
obtained from 9 provinces: spanning the most recent year on record 
(2014–2015) and going back to the earliest year reporting was available 
(2000–2001). Based on the available information (see Supplementary 
File 31) an exploratory effort was performed to: (i) examine national and 
provincial trends and frequencies of (insurance) reimbursement records 
for BCT; (ii) normalize numbers of BCT claims per 10,000 people based 
on population estimates from Statistics Canada [34] and per 1000 indi-
viduals with asthma [35]; and (iii) correlate the number of BCT claims 
with the prevalence of professionals (i.e., respirologists, allergists, inter-
nists, and general practitioners) based on estimates from the Canadian 
Medical Association Masterfile [36]. The correlation between the num-
ber of BCT claims and various health variables were also investigated 
(e.g., population with asthma, location of physician training, and health 
expenditures). For all computations, SPSS version 24 and bootstrapping 
(resampled 2000 times) were used to obtain confidence intervals for 
all correlations. Bootstrapping is a commonly used technique that simu-
lates multiple potential samples based on the available data to provide 
estimations that do not rely on the classical assumptions of statistical 
inference.
Could BCT be over-prescribed?
From consultations with asthma experts who harbour decades-long opera-
tional insights into the diagnosis of asthma in Canada (Dr. Ronald 
Dandurand, written communication, May 2016; Dr. André Cartier, writ-
ten communication, August 2016; Dr. Jean-Luc Malo, written communi-
cation, July 2016; Dr. James Martin, written communication, August 
2016; Dr. Larry Lands, written communication, May 2016; Dr. Francisco 
Noya, written communication, September 2016) emerged the question of 
whether BCT is under- or over-prescribed across the nation. To this aim, 
an informal, “back-of-the-envelope” calculation was performed using sim-
plified assumptions—to be taken with a pinch of salt. To form a rough 
provincial estimate of the percentage of asthmatics who had BCT over the 
past 15 years (the period of available data), the total number of claims 
throughout 2000–2014 was divided by the number of people with asthma 
in 2014 (the most comprehensive figures available from Statistics Canada) 
[35] for each individual province. In sum, this procedure highlights the 
total number of BCT claims as a percentage of the number of asthmatics— 
a rough index to the number of asthmatics who received BCT.
RESULTS
Figure 1 displays data for the number of medical claims for BCT. Two 
provinces markedly contrast with the others when controlled for popula-
tion or alternatively for population with asthma: physicians from Québec 
perform four times more tests per year (the highest ratio), whereas physi-
cians from Alberta perform nearly eight-fold fewer tests (the lowest 
ratio). Table 1 depicts correlations and confidence intervals of BCT 
claims per capita. Correlation analyses revealed a moderate relationship 
between number of respirologists and BCT claims (Model 1 in Table 1 
and Figure 2). A visual inspection of Figure 3 suggests that Alberta, 
British Columbia, and Saskatchewan differ considerably from the rest of 
the other provinces in terms of their BCT and respirologist ratios. A 
second, exploratory correlation analysis without these provinces was 
therefore performed (Model 2 in Table 1), which greatly strengthened 
the correlation between BCT claims and respirologists. In general, these 
“outliers” seem to cluster on the West coast (Figure 4). Geographic 
region only seems to meaningfully modulate the correlation between 
BCT claims and respirologists (Table 1). Finally, Figure 5 shows clear 
differences among provinces in the estimated percentage of asthmatics 
with BCT over the past 15 years.
1Supplementary data are available with the article through the journal Web site 
at https://www.cjrt.ca/?wpdmdl=695
DISCUSSION
Compared with other provinces, the number of tests in Québec is four 
times higher; in Alberta, it is eight-fold lower—acknowledging popula-
tion size and asthma rates. The higher rate of Québec respirologists 
(per capita) may partly explain this higher rate of BCT. However, 
Canada’s geography seems to moderate the correlation between the 
number of tests and respirologists: there were fewer tests per respirolo-
gist in the West (i.e., Alberta, Saskatchewan, and British Columbia, 
with the exclusion of Manitoba). Other variables—including numbers 
of allergists and internists, location of completion of medical training, 
population, percentage of urban population, population density, 
and health expenditures—also correlate with the number of tests, 
albeit more weakly. Moreover, the current interpretation of these 
 findings alongside the ratios of BCTs to asthmatics, as illustrated in 
Figure 5, suggest that Québec and Ontario aside, Canada may be 
under-utilizing BCT.
How many tests?
Published reports document that between roughly 60% [28] and 90% 
[32] of adults show normal spirometry despite respiratory symptoms. 
Assuming Canada manages asthma in congruence with the asthma 
guidelines [2], the proportion of asthmatics getting BCT should loosely 
match the percentages of these reports. Between 2000 and 2014 it is 
estimated (see Figure 5) that the equivalent of nearly 60% of asthmatics 
went through BCT in Québec, whereas in Ontario this number was just 
a hair over 30%. These two provinces contrast with the rest of Canada 
that all lie under the 25% threshold. In addition, medical specialists are 
more likely to recommend PFT compared with general practitioners [23, 
24, 42]. This paper shows that the use of BCT relates to the number of 
respirologists, allergists, and internists, but not to the number of general 
practitioners; however, most Canadian provinces seem to shy away from 
BCT. Overall, this trend echoes an overarching tendency to discount the 
guidelines of the Canadian Asthma Consensus: for example, to confirm 
the diagnosis of asthma objectively given that almost 50% of patients 
reported having never received a lung function test [21].
Ignoring asthma guidelines may have important consequences. One 
study [10] estimated that the improper diagnosis of asthma due to a lack 
of objective PFT could cost Canadians more than $275 million over a 
50-year period. There is also some evidence that provinces differ in their 
misdiagnosis rates. Data from a recent survey of 10 Canadian cities [12, 
22] suggest that over-diagnosis of asthma may be higher in western prov-
inces (Manitoba, 49%; British Columbia, 48%; Alberta, 44%) and lower 
in eastern provinces (Ontario, 39%; Nova Scotia, 29%; Québec, 24%).2 
Furthermore, this regional distribution seems to follow the general pat-
tern identified earlier regarding the relation between respirologists and 
BCT (Figure 4). These findings raise the possibility that regional varia-
tion in BCT translates to similar variations in misdiagnosis rates.
Potential reasons for variation in BCT in Canada
Why provinces differ in their use of BCT remains unclear; a wide array 
of complex factors and interactions is likely at play (see Table 1 for exam-
ples). For instance, to obtain financial compensation in Québec, workers 
need to confirm the diagnosis of occupational asthma with objective 
tests [43, 44]. Moreover, Québec reportedly possesses a higher concentra-
tion of occupational and exercise-induced asthma specialists (Dr. Sandra 
D. Anderson, written communication, July 2016; Dr. Alan Kaplan, 
 written communication, July 2016), and individuals with occupa-
tional asthma may undergo BCT multiple times, typically 4–10 times 
(Dr. André Cartier, oral communication, June and December, 2016). 
Counterintuitively, the number of pulmonary function laboratories per 
province and the reimbursed amount physicians receive for conducting 
or interpreting the test hardly relates to BCT rates (see the figure in 
Supplementary File 51).
2Misdiagnosis rates by province were computed by averaging data from the 10 
Canadian cities surveyed in the study and using the same methodology as the 
authors (number of participants who completed the study algorithm/number of 
people for whom the diagnosis of asthma was ruled out on serial testing).
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Several asthma specialists interviewed also pointed out that the med-
ical culture in Québec emphasizes the objective confirmation of asthma 
diagnosis (Dr. Jean-Luc Malo, written communication, May 2016; Dr. André 
Cartier, oral communication, June 2016; Dr. Ronald Olivenstein, 
written communication, May 2016; Dr. James G. Martin, written com-
munication, July 2015; Ms. Sandra Di Palma, written communication, 
July 2015). Concurrently, outside of Québec, practitioners may dispar-
age the value and clinical utility of BCT (Dr. Donald W. Cockcroft, 
TABLE 1
Correlation analyses of number of BCT claims, per capita, for the Canadian provinces
Measure (by number of BCT claims, per capita, 2000–2014)
Degrees of freedom  
(n – 2) Correlation (r) p
Bootstrapped 95% 
confidence interval
Respirologists [36], per capita; Model 1 132 0.582*** <0.001 [0.421, 0.716]
Respirologists, per capita (excluding AB, BC, and SK); Model 2 87 0.930*** <0.001 [0.883, 0.958]
Allergists [36], per capita; Model 1 132 0.718*** <0.001 [0.649, 0.785]
Allergists, per capita (excluding AB, BC, and SK); Model 2 87 0.747*** <0.001 [0.656, 0.838]
General internists [36], per capita; Model 1 132 0.210* 0.015 [0.105, 0.328]
General internists, per capita (excluding AB, BC, and SK); Model 2 87 0.186 0.080 [0.050, 0.325]
General practitioners [36], per capita 132 −0.071 0.418 [−0.181, 0.045]
General practitioners, per capita (excluding AB, BC, and SK); Model 2 87 −0.170 0.112 [−0.310, −0.031]
MD degree received from foreign university [35]a 132 −0.533*** <0.001 [−0.642, −0.403]
Estimated population with asthma [38]b, per capita 88 0.052 0.623 [−0.090, 0.193]
Population [34] 132 0.626*** <0.001 [0.576, 0.688]
Percentage of urban population [39]c 25 0.451* 0.018 [0.227, 0.664]
Population density [40]c 25 0.628*** <0.001 [0.442, 0.865]
Health expenditures [41], per capita 132 −0.183* 0.034 [−0.330, −0.023]
Public health expenditures, per capita 132 −0.233** 0.007 [−0.374, −0.078]
Private health expenditures, per capita 132 −0.003 0.974 [−0.180, 0.179]
Administration expenditures, per capita 132 −0.254** 0.003 [−0.330, −0.179]
Capital expenditures, per capita 132 −0.037 0.668 [−0.205, 0.140]
Drug expenditures, per capita 132 0.147 0.090 [−0.050, 0.321]
Hospital expenditures, per capita 132 −0.326*** <0.001 [−0.447, −0.186]
Other health spending expenditures, per capita 132 −0.184* 0.033 [−0.311, −0.043]
Other institutional expenditures, per capita 132 0.100 0.248 [−0.046, 0.239]
Other professional expenditures, per capita 132 −0.083 0.341 [−0.232, 0.088]
Physician expenditures, per capita 132 −0.101 0.247 [−0.270, 0.093]
“Public health” expenditures, per capita 132 −0.429*** <0.001 [−0.546, −0.295]
*p < 0.05; **p < 0.01; ***p < 0.001.
Note: This table does not present an exhaustive list. Bold text indicates a statistically significant difference. AB = Alberta; BC = British Columbia; SK = Saskatchewan.
aThese data from the Canadian Institute for Health Information’s Supply, Distribution and Migration of Canadian Physicians includes all physicians (family medicine 
and specialists). For the correlations, the percentage of physicians who obtained their medical training outside Canada was used.
bEstimated population with asthma was only available for years 2003, 2005, and 2007–2014.
cPercentages of urban population and population density were only available from the 2001, 2006, and 2011 censuses.
FIGURE 1
Total number of medical claims for bronchial challenge testing for 2000–2001 to 2014–2015. This presentation, rather than 
using a logarithmic scale, illustrates how the provinces of Québec and Ontario stand out from the rest. L = Newfoundland 
and Labrador, P = Prince Edward Island, N = New Brunswick, Q = Québec, O = Ontario, M = Manitoba, S = Saskatchewan, 
A = Alberta, B = British Columbia. 
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written communication, July 2015)—although this does not mean they 
necessarily disagree with the objective confirmation of asthma using 
alternative methods such as spirometry and peak flow measurement. As 
a case in point, the use of spirometry depends on whether physicians 
believe it necessary to pose an accurate diagnosis [24]. This paper shows 
that completing medical training outside of Canada relates to fewer BCT 
claims; Québec physicians are correspondingly much more likely to 
obtain their medical training in Canada than physicians from other 
provinces [35]. Perhaps the influence of prominent Canadian experts 
(e.g., Freddy Hargreave [45, 46] and his protégées [47, 48], and the 
Montréal group, including the Meakins-Christie Laboratories [49]) lin-
gers as a factor still governing the higher BCT rates in eastern Canada 
and Québec today.
Limitations
The following overarching caveats apply to this study. (i) Nova Scotia and 
Newfoundland and Labrador provided partial or complete omissions of 
data (see Supplementary file 21). (ii) The term “BCT” is hardly uniform 
across provinces (see Supplementary file 11). (iii) Although a reasonable 
approximation, medical claims may under-estimate the true number of 
tests—for instance, in Alberta, several groups with alternative payment 
plans do not always report their activities fully (Dr. Stephen K. Field, 
written communication, August 2016; Mr. David Onyschuk, written 
communication, September 2016). Similarly, in Québec, physicians 
working in children’s hospitals sometimes have alternative payment 
plans that prevent them from claiming BCT (Dr. Jacques-Édouard 
Marcotte, written communication, August 2016; Dr. Larry Lands, 
FIGURE 3
Provinces sorted by magnitude of the difference between the average number of bronchial challenge tests per 1000 
population (in blue) and the average number of respirologists per 10,000 population (in orange), 2000–2014. Provinces to 
the left indicate greater positive difference, while provinces to the right indicate greater negative difference.
FIGURE 2
Number of bronchial challenge tests per 1000 population in relation to the number of respirologists per 10,000 population 
for each province, 2000–2014. L = Newfoundland and Labrador, P = Prince Edward Island, N = New Brunswick, Q = Québec, 
O = Ontario, M = Manitoba, S = Saskatchewan, A = Alberta, B = British Columbia.
Patterns of bronchial challenge testing in Canada
Can J Respir Ther Vol 54 No 2 Summer 2018 45
written communication, May 2016). Under-reporting of medical claims 
may occur in other provinces as well.
Important limitations also apply to the procedure for estimating the 
number of asthmatics who had BCT. First, provinces with a greater pro-
portion of individuals followed for occupational asthma (e.g., Québec) 
may have inflated numbers, assuming these individuals undergo BCT 
more than once. Furthermore, the total number of tests only covers the 
past 15 years, whereas asthmatics may have undergone BCT before this 
period, hence this analysis likely under-estimates the actual number of 
asthmatics who received BCT. However, the procedure used estimates 
from Statistics Canada for the number of people who report having 
received a diagnosis of asthma by their physician [38]—these individuals 
may or may not have received BCT. This last limitation may actually 
provide more support for this estimation because including cases in 
which BCT excluded the diagnosis of asthma would further decrease the 
percentages of suspected asthmatics who had BCT, and reinforce the 
hypothesis that most provinces under-use BCT. And yet, this procedure 
provides but a rough estimation of the number of asthmatics who 
received BCT.
CONCLUSION
This paper shows substantial interprovincial variations in the use of 
BCT. These findings expand our understanding of the diagnosis of 
asthma in Canada by highlighting the critical role of respirologists and 
the moderating effect of geographic region. A tentative analysis also sug-
gests that certain provinces may be under-prescribing BCT, thereby 
increasing risks for misdiagnosis of asthma and associated health care 
costs. Overall, this investigation complements earlier research on the 
misdiagnosis of asthma [10–18, 21–24] and contributes to a more system-
atic understanding of the use of objective testing in asthma. Future 
research should address the possibility of under-reporting in the current 
study, as well as the reliance on a rough approximation to determine how 
many individuals diagnosed with asthma underwent BCT. To detect and 
address the misdiagnosis of asthma specifically, the respiratory medicine 
FIGURE 4
Difference between average number of bronchial challenge tests per 1000 population and average number of respirologists 
per 10,000 population, 2000–2014 (see Figure 3). Red indicates a greater negative difference, while green indicates no 
difference or a positive difference. Figure produced with Heatmapper.ca online software available at http://www.heatmapper.
ca/geomap/ [37].
FIGURE 5
Total number of bronchial challenge tests for 2000–2014, by province, divided by the estimated number of individuals with 
asthma in 2014 (estimation by Statistics Canada). The 50% (green) and 25% (red) thresholds are only for reference.
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community would stand to benefit, over and beyond documenting PFT, 
from a more precise and thorough assessment of clinicians’ adherence to 
the Canadian guidelines when diagnosing and managing asthma.
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